The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial

BACKGROUND: Artemether-lumefantrine (AL) is the most widely used artemisinin-based combination therapy in Sub-Saharan Africa and is threatened by the emergence of artemisinin resistance. Dosing is suboptimal in young children. We hypothesized that extending AL duration will improve exposure and redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Whalen, Meghan E, Kajubi, Richard, Goodwin, Justin, Orukan, Francis, Colt, McKenzie, Huang, Liusheng, Richards, Kacey, Wang, Kaicheng, Li, Fangyong, Mwebaza, Norah, Aweeka, Francesca T, Parikh, Sunil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907485/
https://www.ncbi.nlm.nih.gov/pubmed/36130191
http://dx.doi.org/10.1093/cid/ciac783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907485/
https://www.ncbi.nlm.nih.gov/pubmed/36130191
http://dx.doi.org/10.1093/cid/ciac783

Ejemplares similares